CSS
MRNA icon

Cubist Systematic Strategies’s Moderna MRNA Stock Holding History

Cubist Systematic Strategies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.26M Sell
48,641
-203,368
-81% -$5.67M 0.01% 1837
2025
Q2 		$6.95M Buy
+252,009
New +$6.64M 0.03% 816
2025
Q1 		– Sell
-55,802
Closed -$1.98M – 3270
2024
Q4 		$2.32M Buy
+55,802
New +$2.67M 0.01% 1264
2024
Q1 		– Sell
-19,541
Closed -$1.97M – 4088
2023
Q4 		$1.94M Buy
+19,541
New +$1.64M 0.01% 1538
2023
Q2 		– Sell
-1,357
Closed -$181K – 4007
2023
Q1 		$208K Sell
1,357
-12,880
-90% -$2.12M ﹤0.01% 3209
2022
Q4 		$2.56M Sell
14,237
-47,037
-77% -$7.69M 0.01% 1642
2022
Q3 		$7.25M Sell
61,274
-10,473
-15% -$1.59M 0.04% 732
2022
Q2 		$10.2M Buy
71,747
+25,808
+56% +$3.69M 0.06% 423
2022
Q1 		$7.91M Buy
45,939
+18,467
+67% +$3.11M 0.07% 425
2021
Q4 		$6.98M Buy
27,472
+7,820
+40% +$2.29M 0.07% 441
2021
Q3 		$7.56M Sell
19,652
-1,486
-7% -$548K 0.1% 282
2021
Q2 		$4.97M Sell
21,138
-10,645
-33% -$1.9M 0.06% 541
2021
Q1 		$4.16M Sell
31,783
-47,205
-60% -$6.84M 0.05% 545
2020
Q4 		$8.25M Buy
78,988
+37,499
+90% +$3.79M 0.11% 223
2020
Q3 		$2.94M Buy
41,489
+34,158
+466% +$2.38M 0.04% 678
2020
Q2 		$471K Buy
+7,331
New +$401K 0.01% 1615
2019
Q3 		– Sell
-144,610
Closed -$2.12M – 2374
2019
Q2 		$2.12M Buy
+144,610
New +$3.11M 0.04% 656

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cubist Systematic Strategies's MRNA Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Moderna (MRNA) stake by 81% in Q3 2025, selling an estimated $5.67M and leaving 48,641 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #1837.

Cubist Systematic Strategies first reported a position in MRNA in Q2 2019 and has held it in 17 quarters since. The position peaked at $10.2M in Q2 2022. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Cubist Systematic Strategies held 48,641 shares of Moderna worth $1.26M as of Q3 2025.
  • Cubist Systematic Strategies sold 203,368 Moderna shares in Q3 2025, an estimated $5.67M.
  • Moderna made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1837 holding.
  • Cubist Systematic Strategies first reported a position in Moderna in Q2 2019 and has held it in 17 quarters since.
  • Cubist Systematic Strategies's Moderna position peaked at $10.2M in Q2 2022.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.